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High Neutrophil to Lymphocyte Ratio Predicts Larger Infarct Size and Worse
Short-term Outcomes in Patients with Non-ST elevation Myocardial Infarction
Naoki Misumida, Akihiro Kobayashi, John Fox, Yumiko Kanei
Mount Sinai Beth Israel, New York, NY
BACKGROUND High neutrophil to lymphocyte (N/L) ratio has been reported to have a
strong predictive value for worse clinical outcomes in patients with ST elevation
myocardial infarction. However, the clinical signiﬁcance of high N/L ratio in the
setting of non-ST elevation myocardial infarction (NSTEMI) has not been fully
elucidated.
METHODS We performed a retrospective analysis of 481 consecutive patients with
NSTEMI who underwent coronary angiography within ﬁve days after presentation.
Patients with suspected infection, chronic steroid use and active malignancy were
excluded. White blood cell, neutrophil and lymphocyte count were obtained from the
initial blood sample. Patients were categorized into a high N/L ratio group and control
group. Baseline and angiographic characteristics, in-hospital revascularization pro-
cedures, heart failure as well as in-hospital major adverse cardiac event (MACE)
including death, recurrent myocardial infarction, and target vessel revascularization
were compared between the two groups.
RESULTS Among 456 patients included in the ﬁnal analysis, the median N/L ratio
was 3.47 (interquartile range; [2.16-5.57]). The optimal cutoff value in predicting in-
hospital MACE was 5.44 by receiver operating characteristic curve analysis (area
under the curve was 0.84). As a result, 118 patients (25.9%) were categorized into
the high N/L ratio group. Patients with high N/L ratio were older (70[61-80] years
vs. 65[56-74] years, p¼0.003) and had higher white blood cell count (10.1[8.0-12.4]
x109/L vs. 7.9 [6.4-9.7] x109/L, p<0.001) and peak troponin I value (2.22[0.30-11.8]
ng/mL vs. 0.39[0.08-3.95] ng/mL, p<0.001). Other baseline characteristics were
comparable between the two groups. Patients with high N/L ratio had a higher rate
of three-vessel disease (including left main disease) (36.4% vs. 23.7%, p¼0.007).
There was no signiﬁcant difference in the rate of impaired coronary ﬂow and
in-hospital revascularization. Patients with high N/L ratio had a higher rate of
in-hospital MACE (5.9% vs. 0.3%, p<0.001) and in-hospital heart failure (23.7% vs.
11.5%, p¼0.001) compared with the control group. In contrast, the absolute white
blood cell count was not associated with in-hospital MACE or in-hospital heart
failure.
CONCLUSION High N/L ratio was signiﬁcantly associated with a larger infarct size
indicated by peak troponin I value, and a higher rate of three-vessel disease and in-
hospital MACE in patients with NSTEMI.CRT-120
Percutaneous Coronary Intervention of Elderly Patients with Acute Myocardial
Infarction: The Next Big Challenge
Lucas Christianson, Leonardo Clavijo, David Shavelle, Michael Gaglia, Ray Matthews,
Anhilkumara Mehra
USC, Los Angeles, CA
BACKGROUND Acute myocardial infarction has a higher prevalence in elderly pa-
tients however they are underrepresented in clinical trials.
OBJECTIVES The goal of the study is to investigate baseline risk factors, interven-
tional characteristics and hospital outcomes in elderly patients undergoing percuta-
neous coronary intervention (PCI) for acute myocardial infarction (AMI).
METHODS Retrospective analysis of 1309 patients treated with PCI for acute
myocardial infarction (AMI) at the Los Angeles County Hospital þ USC Medical Center
and Keck Medical Center of USC between January 2008 and June 2014. Patients were
divided into 2 groups: age greater than 75 years (group A) and age 75 years or less
(group B).
RESULTS Group A had higher in-hospital morbidity (23.33% vs. 16.13% P¼0.03)
and mortality (20.67% vs. 3.71% P<0.0001). Hospitalizations and intensive care
unit stays were longer (9.6714.68 days vs. 5.707.30 days P¼0.002) and
(5.998.23 days vs. 4.165.46 days P¼0.04), respectively. Post-cardiac catheteri-
zation group A had more acute renal insufﬁciency (12.67% vs. 3.62% P<0.0001)
and cerebral vascular accidents (2.67% vs. 0.69% P¼0.04). There was no difference
in bleeding complications between the two groups. Although, group A was
more likely to require intra-aortic balloon pump support (27.33% vs. 13.11%
P<0.0001); they were less likely to receive glycoprotein IIb/IIIa inhibitors (20.0%
vs. 29.59% P¼0.01), angiotensin-converting enzyme inhibitors or angiotensin
receptor blockers (49.33% vs. 72.30% P<0.0001), and beta-blockers (66.67% vs.
83.26% P¼0.03).
CONCLUSION Despite advancements in PCI and the adjuvant management of AMI,
advanced age remains an important predictor of procedural complications and is
associated with a seven-fold increase risk of in-hospital death. Elderly patients are
less likely to receive angiotensin inhibition and beta-blockers after AMI, which may
also impact their long-term outcome. Future studies designed to investigate and
optimize the management of AMI in elderly patients are needed.CRT-121
ST-segment Elevation Myocardial Infarction Resulting from Stent Thrombosis in
Contemporary Real-world Practice
Yumiko Kanei, Parth Makker, Naoki Misumida, Madeeha Saeed, John Fox
Mount Sinai Beth Israel, New York, NY
BACKGROUND Stent thrombosis is a most devastating event that occurs after
percutaneous coronary intervention (PCI), which can lead to large myocardial
infarction and death. In randomized trial, newer generation drug-eluting stent and
newer antiplatelet therapy have shown to lower the incidence of stent thrombosis.
The aim of our study was to describe the pattern of the patients who presented with
ST-segment elevation myocardial infarction (STEMI) due to stent thrombosis in our
real-world practice.
METHODS This is a single-center retrospective study of 527 patients who presented
with STEMI from 2007 to early 2014. The treatment strategy was at the discretion of
the treating physician. Stent thrombosis (ST) was deﬁned based on the angiographic
ﬁnding (deﬁnite ST). Clinical and procedural characteristics were compared between
the patients with and without ST. The detailed information for patients with ST
regarding the type of previous stent, timing of event, and the use of dual antiplatelet
therapy (DAPT) were reviewed.
RESULTS Among 527 patients with STEMI, 57 patients (11%) had angiographically
conﬁrmed stent thrombosis. The prevalence of hypertension, diabetes mellitus,
dyslipidemia were higher in patients with ST than patients without ST. Patients with
ST had higher median CPK (CPK 2319 vs 1508) and lower left ventricular function (37 þ
5% vs 44 þ 16%), but there was no difference in in-house mortality (2% vs 4%). ST
occurred early (<1 month) in 30%, and very late (>1 year) in 56%. The previous stents
were bare-metal stent in 19%, 1st generation drug-eluting stent in 33%, and 2nd
generation drug-eluting stent in 40%. 48% of patients were taking DAPT (100% of
acute ST, 79% of subacute ST, 38% of late ST, and 19% of very late ST). Premature
cessation of DAPT was seen only in 12%. In 12% of patients, DAPT was held by the
physician for procedures.
CONCLUSION In our cohort of patients, ST was a cause for STEMI in 11% of patients.
Patients who presented with ST had more comorbidity, but in-house mortality was
similar to non-ST patients. ST was seen in variety of clinical setting regarding the
timing, the previous stent, and the concomitant DAPT use. ST is rare but continue to
exist in current era.CRT-122
Elevated Left Ventricular End Diastolic Pressure is an Independent Predictor of
Contrast Induced Nephropathy in Patients with ST Segment Elevation Myocardial
Infarction Undergoing Percutaneous Coronary Intervention
Michael Ruisi, Nitin Kabra, Justin Ratcliffe, John Fox, Yumiko Kanei
Mount Sinai Beth Israel Medical Center, New York, NY
BACKGROUND Contrast induced nephropathy (CIN) has been reported in up to 19% of
patients undergoing primary percutaneous coronary intervention (PCI) for ST
segment elevation myocardial infarction (STEMI). A recent study showed that a
hydration strategy based on left ventricular end diastolic pressure (LVEDP)
decreased the incidence of CIN in patients undergoing PCI. Our study explores the
relationship between LVEDP and the incidence CIN in patients with STEMI under-
going PCI.
METHODS Patients with STEMI who underwent emergent PCI at our hospital from
2005-2013 were retrospectively analyzed. The PCI and hydration strategies were at
the discretion of the operator. CIN was deﬁned as an increase in creatinine of more
than 0.5mg/dL or 25% from baseline, within 72 hours post procedure. Patients were
categorized into two groups according to LVEDP values measured at the time of
cardiac catheterization: LVEDP 19 mmHg (n¼ 196), and LVEDP <19 mm Hg (n¼ 76).
The clinical and procedural characteristics and incidence of CIN were compared be-
tween the 2 groups. Multivariate regression analysis was performed to evaluate for
independent risk factors for CIN.
RESULTS Out of 272 patients analyzed, a total of 48 patients (17.6%) developed CIN.
Baseline creatinine levels, the prevalence of diabetes mellitus, and the incidence of
anterior wall myocardial infarction were similar in CIN group and non-CIN group.
Patients with LVEDP19 mmHg had statistically signiﬁcant higher cardiac enzyme
than patients with LVEDP<19. The incidence of CIN in patients with an
LVEDP 19 mm Hg was 41 (21%) compared to 7 (9.2%) in patients with LVEDP < 19 mm
Hg. This was statistically signiﬁcant with a chi square statistic of 5.16 with p-val-
ue¼0.02. A multivariate regression analysis was performed which showed that an
LVEDP 19 mm Hg, as well as intra-aortic balloon pump use and age are independent
predictors of CIN in our STEMI cohort.
CONCLUSION In patients with STEMI who underwent emergent PCI, an elevated
LVEDP at the time of catheterization was associated with increased incidence
of CIN. An LVEDP 19 mm Hg portends a statistically signiﬁcant higher risk
for CIN in this population and hydration strategies may need to be adjusted
accordingly.
